An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs

被引:9
作者
Couvelard, Anne [1 ]
Cros, Jerome [1 ]
机构
[1] Univ Paris Cite, Bichat & Beaujon AP HP Hosp, ENETS Ctr Excellence, Dept Pathol, 46 Rue Henri Huchard, F-75018 Paris, France
关键词
Digestive neuroendocrine tumour; Neuroendocrine carcinoma; Classification; Biomarkers; ACINAR-CELL CARCINOMA; GRADE; 3; PROGNOSTIC-FACTORS; PROTEIN-1; INSM1; TUMORS; EXPRESSION; KI-67; G3; SYNAPTOPHYSIN; HETEROGENEITY;
D O I
10.1007/s00428-022-03306-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Digestive neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms found throughout the digestive tract, with different behaviour and genetic background. In the last few years, nomenclature and WHO/UICC classifications of digestive NENs have changed, and molecular classifications have emerged, especially in pancreatic locations. Increasing patho-molecular details are needed to diagnose the different categories of NEN, including the use of helpful immunohistochemical markers. In this review, we address these topics in three successive chapters. We first briefly review recent updates in classifications, discuss important grading and proliferating issues and advances in the molecular understanding of NEN. Then, we provide an update on diagnosis, including the most important differential diagnoses of NEN, with a focus on high-grade neoplasms and mixed tumours. Finally, we highlight a variety of currently used and next-generation predictive and prognostic biomarkers as well as biomarkers of tumour origin and describe some site specificities of gastrointestinal NEN. We specifically focus on biomarkers available to pathologists with the potential to change the way patients with NEN are diagnosed and treated.
引用
收藏
页码:1129 / 1148
页数:20
相关论文
共 125 条
[1]   Gastrointestinal neuroendocrine tumors in 2020 [J].
Ahmed, Monjur .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (08) :791-807
[2]   Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma [J].
Ali, Abir Salwa ;
Gronberg, Malin ;
Federspiel, Birgitte ;
Scoazec, Jean-Yves ;
Hjortland, Geir Olav ;
Gronbaek, Henning ;
Ladekarl, Morten ;
Langer, Seppo W. ;
Welin, Staffan ;
Vestermark, Lene Weber ;
Arola, Johanna ;
Osterlund, Pia ;
Knigge, Ulrich ;
Sorbye, Halfdan ;
Grimelius, Lars ;
Janson, Eva Tiensuu .
PLOS ONE, 2017, 12 (11)
[3]   The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging [J].
Amin, Mahul B. ;
Greene, Frederick L. ;
Edge, Stephen B. ;
Compton, Carolyn C. ;
Gershenwald, Jeffrey E. ;
Brookland, Robert K. ;
Meyer, Laura ;
Gress, Donna M. ;
Byrd, David R. ;
Winchester, David P. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) :93-99
[4]  
[Anonymous], 2017, WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs
[5]   The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms [J].
Basturk, Olca ;
Yang, Zhaohai ;
Tang, Laura H. ;
Hruban, Ralph H. ;
Adsay, Volkan ;
McCall, Chad M. ;
Krasinskas, Alyssa M. ;
Jang, Kee-Taek ;
Frankel, Wendy L. ;
Balci, Serdar ;
Sigel, Carlie ;
Klimstra, David S. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (05) :683-690
[6]   Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? [J].
Bellizzi, Andrew M. .
HUMAN PATHOLOGY, 2020, 96 :8-33
[7]   Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors [J].
Bellizzi, Andrew M. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (02) :185-+
[8]   SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas [J].
Bellizzi, Andrew M. .
HISTOPATHOLOGY, 2020, 76 (02) :251-264
[9]   Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia [J].
Boesch, Florian ;
Bruewer, Katharina ;
Altendorf-Hofmann, Annelore ;
Auernhammer, Christoph J. ;
Spitzweg, Christine ;
Westphalen, C. Benedikt ;
Boeck, Stefan ;
Schubert-Fritschle, Gabriele ;
Werner, Jens ;
Heinemann, Volker ;
Kirchner, Thomas ;
Angele, Martin ;
Knoesel, Thomas .
ENDOCRINE-RELATED CANCER, 2019, 26 (03) :293-301
[10]   High-Grade Progression Confers Poor Survival in Pancreatic Neuroendocrine Tumors [J].
Botling, Johan ;
Lamarca, Angela ;
Bajic, Duska ;
Norlen, Olov ;
Lonngren, Vincent ;
Kjaer, Josefine ;
Eriksson, Barbro ;
Welin, Staffan ;
Hellman, Per ;
Rindi, Guido ;
Skogseid, Britt ;
Crona, Joakim .
NEUROENDOCRINOLOGY, 2020, 110 (11-12) :891-898